Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Metastatic Colorectal Cancer (BRECOL)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01733628 |
|
Recruitment Status
: Unknown
Verified June 2013 by Spanish Breast Cancer Research Group.
Recruitment status was: Recruiting
First Posted
: November 27, 2012
Last Update Posted
: May 19, 2015
|
Sponsor:
Spanish Breast Cancer Research Group
Collaborator:
Roche Farma, S.A
Information provided by (Responsible Party):
Spanish Breast Cancer Research Group
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Unknown |
|---|---|
| Actual Primary Completion Date : | December 2013 |
| Estimated Study Completion Date : | December 2015 |